科研之友
微信
新浪微博
Facebook
分享链接
摘要
treatment of chronic hepatitis c virus (hcv) infection in human immunodeficiency virus (hiv) infected patients has become a topic of great importance, since the complications of chronic hepatitis are the first one cause of mortality among hiv patients. the aim of this study is to review the biological and epidemiological data in hiv-hcv coinfection, to establish treatment guidelines taking in consideration drugs adverse effects and interations, and to report the results of the main studies carried out. the treatment currently accepted includes pegylate interferon and ribavirin, wich have improved prior treatments, but the respouse rate depends on hcv genotype
